Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Competitive binding assay for drugs that interfere with calmodulin function.

H Le Vine, N Sahyoun, P Cuatrecasas

    Analytical Biochemistry
    |November 15, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Role of specific membrane lipids in modulating the activity of adenylate cyclase.

    Biophysical journal·2009
    Same author

    Factors produced by activated macrophages reduce accumulation of Alzheimer's beta-amyloid protein in vascular smooth muscle cells.

    Brain research·1997
    Same author

    Promotion of synthetic amyloid beta-peptide fibrillization by cell culture media and cessation of fibrillization by serum.

    Neuroscience letters·1996
    Same author

    Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin.

    The Journal of biological chemistry·1995
    Same author

    Benefits and costs of medical nutrition therapy by registered dietitians for patients with hypercholesterolemia. Massachusetts Dietetic Association.

    Journal of the American Dietetic Association·1995
    Same author

    Relation between beta-carotene intake and plasma and adipose tissue concentrations of carotenoids and retinoids.

    The American journal of clinical nutrition·1995

    A new assay directly measures anti-calmodulin drug activity using a neuronal protein kinase II preparation. This method offers a simpler, more reliable way to test drug effectiveness and understand their mechanisms.

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Pharmacology

    Background:

    • Calmodulin-dependent protein kinase type II (CaMKII) plays a crucial role in neuronal function.
    • Assessing anti-calmodulin drug activity is vital for developing treatments for various neurological disorders.
    • Standard assays, like phosphodiesterase enzyme assays, can be susceptible to drug-specific artifacts.

    Purpose of the Study:

    • To develop a direct and simplified method for assessing anti-calmodulin drug activity.
    • To provide a reliable alternative to existing assays that may be prone to artifacts.
    • To offer a tool for investigating the mechanisms of action of potential anti-calmodulin agents.

    Main Methods:

    • A direct 125I-calmodulin-binding assay was developed.

    Related Experiment Videos

  • The assay utilizes a particulate cytoskeletal preparation of neuronal CaMKII.
  • A rapid filtration-based technique was employed for data acquisition.

    • Main Results:

    • The developed assay provides a simple and rapid method for assessing anti-calmodulin drug activity.
    • Comparable IC50 values were obtained for a range of drugs compared to standard assays.
    • The assay avoids potential artifacts associated with direct drug effects on enzymes like phosphodiesterase.

    Conclusions:

    • The direct 125I-calmodulin-binding assay is a robust tool for evaluating anti-calmodulin drugs.
    • This method enhances the reliability of drug screening and mechanism-of-action studies.
    • It facilitates the exploration of pharmacologic modifications for pathophysiological processes.